Press release article from our research archive:

Aventis Pharmaceuticals' Allegra (fexofenadine HCl) 30-mg tablets now available to treat seasonal allergies and chronic hives in children aged 6 to 11 years.

M2 PRESSWIRE-6 June 2000-Aventis Pharmaceuticals: Aventis Pharmaceuticals' Allegra (fexofenadine HCl) 30-mg tablets now available to treat seasonal allergies and chronic hives in children aged 6 to 11 years (C)1994-2000 M2 COMMUNICATIONS LTD

RDATE:05062000

PARSIPPANY, N.J. -- Aventis Pharmaceuticals announced today that Allegra (fexofenadine HCl) 30-mg tablets, twice daily (BID), are now available by prescription for the relief of seasonal allergic rhinitis (SAR) and chronic idiopathic urticaria (CIU) in children aged 6 to 11 years.

"Seasonal allergies affect up to six million children in the United States," said Eli Meltzer, M.D., of the Allergy and ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!